Treatment of Iron Deficiency
The recommended treatment for iron deficiency is oral iron supplementation with ferrous sulfate 65mg elemental iron daily, administered between meals to maximize absorption, with continuation for 3 months after normalization of hemoglobin to replenish iron stores. 1
Diagnosis Confirmation
Before initiating treatment, proper diagnosis is essential:
Serum ferritin is the most reliable diagnostic test for iron deficiency:
- <30 μg/L: Definitive iron deficiency
- 30-100 μg/L with transferrin saturation <20%: Possible iron deficiency, especially with inflammation
100 μg/L with normal transferrin saturation: Iron deficiency unlikely 1
In patients with inflammation, chronic disease, or malignancy, the ferritin cutoff should be raised to <100 μg/L, with transferrin saturation <16% supporting the diagnosis 1
Oral Iron Therapy
First-Line Treatment
- Ferrous sulfate is the preferred agent, providing approximately 65mg of elemental iron per tablet 1
- Recent evidence suggests alternate-day dosing may improve absorption and reduce side effects:
- Doses ≥60 mg in iron-deficient women stimulate hepcidin, which persists for 24 hours but subsides by 48 hours
- Morning doses are preferable as the circadian increase in plasma hepcidin is augmented by morning iron doses 2
Dosing Recommendations
- Traditional dosing: 100-200 mg/day elemental iron in divided doses 3
- Optimized dosing based on recent evidence:
Expected Response
- Hemoglobin should increase by ≥1 g/dL within 4 weeks of starting therapy 1
- If no response is seen despite compliance, further evaluation is needed 1
Duration of Treatment
- Continue iron supplementation for 3 months after normalization of hemoglobin to replenish iron stores 1
Intravenous Iron Therapy
Intravenous iron is indicated in specific situations:
- Oral iron intolerance or poor response
- Malabsorption syndromes (celiac disease, post-bariatric surgery)
- Inflammatory conditions (inflammatory bowel disease, chronic kidney disease, heart failure)
- Ongoing blood loss exceeding oral replacement capacity
- During second and third trimesters of pregnancy when rapid repletion is needed 4
When IV iron is required:
- Ferric carboxymaltose is well-studied and can be infused over 15 minutes 3
- Risk of reactions is very infrequent (<1:250,000 administrations with recent formulations) 3
Addressing Underlying Causes
Identifying and treating the underlying cause of iron deficiency is essential:
- In men and postmenopausal women: Evaluate for gastrointestinal blood loss
- In premenopausal women: Assess for heavy menstrual bleeding
- Screen for malabsorption conditions (celiac disease, H. pylori infection)
- Evaluate dietary intake patterns 1, 3
Common Pitfalls to Avoid
- Failing to identify the underlying cause of iron deficiency, particularly in men and postmenopausal women
- Using inappropriate ferritin cutoffs in patients with inflammation
- Relying solely on hemoglobin for diagnosis
- Discontinuing treatment too early before iron stores are replenished
- Not addressing gastrointestinal side effects that reduce compliance 1
Follow-up
- Check hemoglobin levels within 4 weeks of starting iron therapy
- Monitor for response (increase of at least 1 g/dL in hemoglobin)
- Continue monitoring after treatment completion as iron deficiency often recurs 1
Iron deficiency treatment should be tailored based on severity, underlying cause, and patient factors, with oral iron supplementation being the cornerstone of therapy for most patients.